Prevalence and predictors of drug use among adolescents with HIV infection acquired perinatally or later in life

AIDS and Behavior

Volumn 17, Issue 3, 2013, Pages 976-986

  Conner, Latoya C ^a   Wiener, Jeffrey ^b   Lewis, Jennifer V ^c   Phill, Rhonda ^d   Peralta, Ligia ^d   Chandwani, Sulachni ^c   Koenig, Linda J ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Drug use; HIV AIDS; Public health

Indexed keywords

ADDICTION; ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; ARTICLE; DEPRESSION; DISEASE TRANSMISSION; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; ONSET AGE; PREDICTIVE VALUE; PREVALENCE; PUBLIC HEALTH; SEXUAL BEHAVIOR; STATISTICS; UNITED STATES; URBAN POPULATION; VERTICAL TRANSMISSION;

ADOLESCENT; ADOLESCENT BEHAVIOR; AGE OF ONSET; BALTIMORE; DEPRESSION; DISTRICT OF COLUMBIA; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; NEW YORK CITY; PREDICTIVE VALUE OF TESTS; PREVALENCE; PUBLIC HEALTH; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS; URBAN POPULATION; YOUNG ADULT;

EID: 84880749984     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-9950-x     Document Type: Article

References (54)

1. Centers for Disease Control and Prevention. CDC HIV/AIDS Fact Sheet: HIV/AIDS among youth. May 4 2009. Available from: http://www.cdc.gov/hiv/ resources/Factsheets/youth.htm.
2. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2007. Vol. 19. [Table 1]. Atlanta: U.S. Department of Health and Human Services; 2009.
3. Wright K. Policing positives [on-line]. Nov 21 2005. Available from: http://www.blackaids.org/ShowArticle.aspx?articletype=SITEFEATURE&articleid= 164&pagenumber=1.
4. Whitmore SK, Hughes DP, Taylor AW, Koenig LJ. Estimated numbers and demographic characteristics of persons living with perinatally acquired HIV disease, 34 States, United States, 2007. 2010 July. Poster presented at the 18th international AIDS conference (Vienna, Austria).
5. Centers for Disease Control and Prevention. Youth risk behavior survey surveillance - United States, 2005. MMWR. 2005;55:14-22.
6. Johnston LD, O'Malley PM, Bachman JG. Monitoring the future national results in adolescent drug use: overview of key findings, 2002. Rockville, MD: National Institute on Drug Abuse; 2002. NIH publication No. 06-5882.
7. Substance Abuse and Mental Health Services Administration. National Survey on Drug Use & Health, Nov 2 2009. Available from: http://www.oas.samhsa.gov/NSDUH/2k4NSDUH/2k4results/2k4results.htm#ch2.
8. Suris JC, Parera N. Sex, drugs and chronic illness: health behaviours among chronically ill youth. Eur J Public Health. 2005;15(5):484-8. (Pubitemid 41456781)
9. Rosenblum A, Magura S, Fong C. Substance use among young adolescents in HIV-affected families: resiliency, peer deviance, and family functioning. Subst Use Misuse. 2005;40:581-603. (Pubitemid 40594393)
10. Houck CD, Lescano CM, Brown LK, Tolou-Shams M, Thompson J, DiClemente R, et al. "Islands of risk": subgroups of adolescents at risk for HIV. J Pediatr Psychol. 2006;31:619-29. (Pubitemid 43999586)
11. Bachanas PJ, Morris MK, Lewis-Gess JK, Sarett-Cuasay EJ, Flores AL, Sirl KS, et al. Psychological adjustment, substance use, HIV knowledge, and risky sexual behavior in at-risk minority females: developmental differences during adolescence. J Pediatr Psychol. 2002;27(4):373-84. (Pubitemid 34552937)
12. Taney MR, Naar-King S, Murphy DA, Parsons JT, Janisse H. Multiple risk behaviors among youth living with Human Immunodeficiency Virus in five U.S. cities. J Adolesc Health. 2010;46:11-6.
13. American Academy of Pediatrics Committee on Pediatric AIDS. Reducing the risk of HIV infection associated with illicit drug use. Pediatrics. 2006;117(2):566-71. (Pubitemid 46071624)
14. Centers for Disease Control and Prevention. Fact sheet: drug-associated HIV transmission continues in the United States. 2007. 2009 Aug 6. Available from http://www.cdc.gov/hiv/resources/factsheets/idu.htm.
15. Kennedy CA, Hill JM, Schleifer SJ. HIV/AIDS and substance use disorders. In: Frances RJ, Miller SI, Mack AH, editors. Clinical textbook of addictive disorders. 3rd ed. New York: The Guilford Press; 2005. p. 411-36.
16. Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, et al. Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr. 2002;31(2):62-9.
17. Zweben JE, Denning P. The alcohol and drug wildcard: Substance use and psychiatric problems in people with HIV. San Francisco: UCSF AIDS Health Project; 1998.
18. Chesney MA, Farmer P, Leandre F, Malow R, Starace F. Human immunodeficiency virus and acquired immunodeficiency syndrome. In: Sabate E, editor. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. p. 95-106.
19. Ammassari A, Trotta MP, Murri R, Castelli F, Narcisco P, Noto P, et al. Correlates and predictors of adherence to highly active retroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(3):S123-7.
20. Comulada WS, Swendeman DT, Rotheram-Borus MJ, Mattes KM, Weiss RE. Use of HAART among young people living with HIV. Am J Health Behav. 2003;27:389-400. (Pubitemid 37123465)
21. Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med. 2005;159:764-70. (Pubitemid 41126841)
22. Naar-King S, Templin T, Wright K, Frey M, Parsons JT, Lam P. Psychosocial factors and medication adherence in HIV-positive youth. AIDS Patient Care STDs. 2006;20:44-7. (Pubitemid 43172781)
23. Lyketsos CG, Treisman GJ. Mood disorders in HIV infection. Psychiatr Ann. 2001;31(1):45-9.
24. Brown G. The impact of HIV/AIDS on the African American woman and child: epidemiology, cultural and psychosocial issues and nursing management. Assoc Black Nurs Faculty J. 2001;12(3):60-2.
25. Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN. Prevalence of DSM-IV - defined mood, anxiety, and substance use disorders in an HIV clinic in the southeastern United States. J Acquir Immune Defic Synd. 2006;42(3):298-306. (Pubitemid 44050007)
26. Colibazzi T, Hsu TT, Gilmer WS. Human immunodeficiency virus and depression in primary care: a clinical review. Prim Care Companion J Clin Psychiatr. 2006;8(4):201-11. (Pubitemid 44371558)
27. Pao M, Lyon M, D'Angelo LJ, Schuman WB, Tipnis T, Mrazek DA. Psychiatric diagnoses in adolescents seropositive for the human immunodeficiency virus. Arch Pediatr Adol Med. 2000;154:240-4. (Pubitemid 30131903)
28. Marhefka SL, Lyon M, Koenig LJ, Orban L, Stein R, Lewis J, et al. Emotional and behavioral problems and mental health service utilization of youth living with HIV acquired perinatally or later in life. AIDS Care. 2009;21(11):1447-54.
29. Williams PL, Leister E, Chernoff M, Nachman S, Morse E, Di Poalo V, et al. Substance use and its association with psychiatric symptoms in perinatally HIV-infected and HIV-Affected adolescents. AIDS Behav. 2010;14:1072-82.
30. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. Psychiatric disorders in youth with perinatally acquired human immunodeficiency virus infection. Pediatr Inf Dis J. 2006;25(5):432-7.
31. Perkins DO, Leserman J, Stern RA, Baum SF, Liao D, Golden RN, et al. Somatic symptoms and HIV infection: relationship to depressive symptoms and indicators of HIV disease. Am J Psychiatr. 1995;152:1776-81.
32. Coleman CL, Holzemer WL, Eller LS, Corless I, Reynolds N, Nokes KM, et al. Gender differences in use of prayer as a self-care strategy for managing symptoms in African Americans living with HIV/AIDS. J Assoc Nurses AIDS Care. 2006;17(4):16-23. (Pubitemid 44038924)
33. Shacham E, Basta TB, Reece M. Symptoms of psychological distress among African Americans seeking HIV-related mental health care. AIDS Patient Care STDs. 2002;22(5):413-21.
34. Abramowtiz S, Koenig LJ, Chandwani S, Orban L, Stein R, LaGrange R, et al. Characterizing social support: global and specific social support experiences of HIV-infected youth. AIDS Patient Care STDs. 2009;23(5):323-30.
35. Michaelis A. Living with HIV from birth into young adulthood: key issues facing a pioneering generation of HIV-positive youth in Baltimore. Workshop presented at the 136th annual meeting and expo of the American Public Health Association, Oct 2008, San Diego.
36. American Medical Association. Guidelines for adolescent prevention services. Chicago, IL: AMA; 1997. Product No. OP020997.
37. Ziv A, Boulet JR, Slap GB. Utilization of physician offices by adolescents in the United States. Pediatrics. 1999;104(1):35-42. (Pubitemid 29315844)
38. Rogers AS, Futterman DK, Moscicki AB, Wilson CM, Ellenberg J, Vermund SH. The REACH project of the adolescent medicine HIV/AIDS research network: design, methods, and selected characteristics of participants. J Adolesc Health. 1998;22:300-11. (Pubitemid 28163251)
39. Beck A, Ward C, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatr. 1961;4:561-71.
40. Roberts R, Lewisohn P, Seeley J. Screening for adolescent depression: a comparison of depression scales. J Am Acad Child Adolesc Psychiatr. 1991;30(1):58-66.
41. Strober M, Green J, Carlson G. Utility of the beck depression inventory with psychiatrically hospitalized adolescents. J Clin Consult Psychol. 1981;49:482-3. (Pubitemid 13235779)
42. Teri L. Depression in adolescence: it's relationship to assertion and various aspects of self-esteem. J Clin Child Psychol. 1982;11:101-6.
43. Leadbeater B, Linares O. Depressive symptoms in black and Puerto Rican adolescent mothers in the first 3 years postpartum. Dev Psychopathol. 1992;4:451-68.
44. Barrera M, Garrison-Jones C. Properties of the Beck depression inventory as a screening instrument for adolescent depression. J Abnorm Child Psychol. 1988;16(3):263-73.
45. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):705-14.
46. Anderson JR. Module 3: assessment issues and strategies in HOPE program training package 2006. Washington, DC: American Psychological Association; 2006:3-58.34.
47. Vega WA, Zimmerman RS, Warheit GJ, Apospori E, Gil AG. Risk factors for early adolescent drug use in four ethnic and racial groups. Am J Public Health. 1993;83(2):185-9. (Pubitemid 23046473)
48. Crepaz N, Marks G. Are negative affective states associated with HIV sexual risk behaviors? A meta-analytic review. Health Psychol. 2001;20:291-9. (Pubitemid 32738614)
49. O'Leary A, Broadwell SD, Yao P, Hasin D. Major depression, alcohol and drug use disorders do not appear to account for the sexually transmitted disease and HIV epidemics in the Southern United States. Sex Transm Dis. 2006;33(7):S70-7.
50. Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2001;13(1):27-40. (Pubitemid 32125499)
51. Cargill V, Stone V. HIV/AIDS: a minority health issue. Med Clin North Am. 2005;89(4):895-912. (Pubitemid 40755549)
52. Marlatt G. Harm reduction: pragmatic strategies for managing high-risk behaviors. New York: The Guilford Press; 1998.
53. Miller WR, Rollnick S. Motivational interviewing: preparing people for change. New York: The Guilford Press; 2002.
54. Prochaska JO, DiClimente CC. Stages of change in the modification of problem behaviors. Sage: Newbury Park; 1992.